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Mycolic acids are essential components of themyco-
bacterial cell wall. In this study, we show that a gene
encoding a reductase involved in the final step of
mycolic acid biosynthesis can be deleted in Myco-
bacterium smegmatis without affecting cell viability.
Deletion ofMSMEG4722 (ortholog ofMycobacterium
tuberculosis Rv2509) altered culture characteristics
and antibiotic sensitivity. The DMSMEG4722 strain
synthesized a-alkyl, b-oxo intermediates of mycolic
acids, which were found esterified to cell wall arabi-
nogalactan. While the precursors could not be iso-
lated directly due to their inherent instability during
base treatment, their presence was established by
prior reduction of the b-oxo group by sodium boro-
hydride. Interestingly, the mutant also accumulated
unsaturated ketones, similar to tuberculenone from
M. tuberculosis, which were shunt products derived
from spontaneous decarboxylation of a-alkyl,
b-oxo fatty acid precursors of mycolic acids.
INTRODUCTION
Mycolic acids are a major and essential component of the lipid-
rich cell envelope of the human pathogen Mycobacterium tuber-
culosis and other related mycobacteria. Found either covalently
attached to the terminal arabinose residues of the mycolyl arabi-
nogalactan-peptidoglycan (mAGP) complex, or as the free
glycolipids, trehalose monomycolate (TMM), trehalose dimyco-
late (TDM), and glucose monomycolate (GMM), these a-alkyl,
b-hydroxyl long-chain fatty acids play an important role in
reduced cell wall permeability (Brennan and Nikaido, 1995; Daffe
and Draper, 1998; Gao et al., 2003; Jackson et al., 1999) and
virulence (Bhatt et al., 2007; Dubnau et al., 2000; Gao et al.,
2003; Glickman et al., 2000; Rao et al., 2006) of mycobacteria.
In M. tuberculosis, a multifunctional type I fatty acid synthase
(FAS-I) synthesizes C16–18 and C24–26 fatty acids in a bimodal
fashion. The former is then channeled to a type-II, multienzyme
complex called FAS-II, which, through its iterative reductive cy-
cles, extends the acyl chain to long-chain meromycolic acids
(C56–64) (Bloch, 1975, 1977; Brindley et al., 1969; Peterson and
Bloch, 1977). Finally, a polyketide synthase, Pks13, catalyzes
the Claisen condensation of a C26 fatty acid and a mero-acid930 Chemistry & Biology 15, 930–939, September 22, 2008 ª2008 Eto yield an a-alkyl, b-oxo acyl intermediate, which in turn is
reduced to form a mature mycolic acid (Gande et al., 2004; Por-
tevin et al., 2004) (Figure 1A). While earlier studies were focused
on identifying genes encoding ‘‘core’’ FAS-II enzymes, little was
known about the final, post-Pks13 step of mycolic acid biosyn-
thesis: the reduction of the b-oxo group to a hydroxyl group
leading to the formation of the mycolic acid motif. Unlike in
mycobacteria, genes encoding enzymes involved in the biosyn-
thesis of mycolic acids are nonessential in corynebacteria, facil-
itating the generation of null mutants. Recently, Lea-Smith et al.
(2007) generated a mutant of Corynebacterium glutamicum
NCgl2385 that had a slow-growth phenotype, and produced
corynomycolate precursors with a b-oxo group. In the same
study, the authors also used bioinformatics to identify Rv2509,
the M. tuberculosis ortholog of NCgl2385, as a possible candi-
date for reduction of the mycolic acid motif (Lea-Smith et al.,
2007). Mycobacterium smegmatis has often been used as a sur-
rogate forM. tuberculosis when studying biosynthetic pathways.
The fast-growing, nonpathogenic M. smegmatis strain is partic-
ularly useful in studying cell wall biosynthesis genes, since it can
tolerate deletion of some genes that are essential in M. tubercu-
losis (Amin et al., 2008; Escuyer et al., 2001). Moreover, while the
two species differ in mero-chain modifications, core enzymes in-
volved in mycolate biosynthesis are interchangeable (Brown
et al., 2007; Parish et al., 2007). We thus chose to address the
role of Rv2509 in mycobacterial mycolic acid biosynthesis by
generating a deletion mutant of MSMEG4722, the M. smegmatis
homolog of Rv2509.
RESULTS
MSMEG4722 and Rv2509 Encode Proteins Structurally
Similar to Short-Chain Reductases/Dehydrogenases
Through the use of bioinformatics, Lea-Smith et al. (2007) identi-
fied M. tuberculosis Rv2509 as the homolog of NCgl2385, the
C. glutamicum reductase involved in mycolic acid motif forma-
tion. The closest match for Rv2509 in the M. smegmatis mc2155
genome was the putative protein MSMEG4722 (Figure 1B). Both
predicted proteins contained conserved active site residues
and residues for NAD/NADP binding (Figure 1B). Predictions of
the three-dimensional (3D) structures of proteins often give in-
sights into potential catalytic properties. We used the @TOME
server to screen for known structures of proteins that were
predicted to be most closely related to Rv2509 (Douguet
and Labesse, 2001). Predictions of E values from TITO andlsevier Ltd All rights reserved
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(A) Schematic representation of the post-FAS-II steps in mycobacterial mycolic acid biosynthesis. AccD4 and AccD5 are acyl-CoA carboxylases, while FadD32 is
an acyl-AMP ligase. It is yet unclear whether the reduction of the b-oxo group occurs while the mycolic acid precursor in still attached to Pks13, or after release
from Pks13 by a thioesterase.
(B) Alignment of amino acid sequences of Rv2509 and MSMEG4722 with 1cyd (PDB file for the structure of Mus musculus carbonyl reductase with NADP and
2-propanol). aHelices and b sheets are indicated above the residues as coils and arrows, respectively. Residues essential for NAD/NADP binding are indicated by
triangles, while the active-site residue is indicated with a star.3D-PSSM servers (121140 and 1.23e-02, respectively) strongly
suggested that 1cyd (Mus musculus carbonyl reductase com-
plexed with NADPH and 2-propanol) was the closest match to
Rv2709 (22% sequence identity). Through use of the 1cyd coor-
dinates and the FUGUE server (Shi et al., 2001), we generated an
in silico 3D structure of Rv2509. The predictions revealed similar
3D structural folds for 1cyd, Rv2509, and theEscherichia coli fatty
acid reductase, FabG (data not shown). Additionally, when the
NADPH moiety from 1cyd was superimposed in the predicted
NADP-binding fold of Rv2509, the predicted distances between
the conserved residues and the cofactor showed a fit similar to
that seen in 1cyd (data not shown). These data suggest thatChemistry & Biology 15, 930–9Rv2509 was likely an NAD/NADP-dependent mycobacterial
reductase. As outlined above, the homologous M. smegmatis
gene MSMEG4722 was chosen for further analysis.
Deletion ofMSMEG4722 inM. smegmatismc2155Alters
Culture Characteristics and Sensitivity to Antibiotics
In order to study the role ofMSMEG4722 in mycolic acid motif for-
mation, we deleted MSMEG4722 in M. smegmatis mc2155 by
specialized transduction (Bardarov et al., 2002) (Figure 2A). The
ability to generate a null mutant indicated that MSMEG4722
was not essential for the viability of M. smegmatis mc2155.
Loss of MSMEG4722 had a remarkable effect on the colony39, September 22, 2008 ª2008 Elsevier Ltd All rights reserved 931
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agar. While the colonies of the parental, wild-type strain
mc2155 were glossy, those of the mutant strain DMSMEG4722
appeared to have a dry surface (Figure 2B). The change was
more apparent when the strains were grown on TSB agar supple-
mented with Tween-80. Unlike colonies of the parental strain,
mc2155, which had a smooth surface, colonies ofDMSMEG4722
had an irregular, convoluted surface (Figure 2B). The
DMSMEG4722 mutant also showed a slightly slower growth
Figure 2. Generation of a MSMEG4722 Null
Mutant
(A) Map of the MSMEG4722 region in the parental
M. smegmatis strain mc2155 and its correspond-
ing region in the DMSMEG4722 mutant. res, gd
resolvase site; hyg, hygromycin resistance gene
from Streptomyces hygroscopicus; sacB, sucrose
counterselectable gene from Bacillus subtilis.
Digoxigenin-labeled probes were derived from
1 kb upstream and downstream flanking se-
quences that were used to construct the knockout
plasmid, and are indicated by thick lines with
diamond-shaped ends. ClaI-digested bands ex-
pected in a Southern blot are indicated in roman
numerals with sizes in parentheses. The inset
shows the Southern blot of ClaI-digested genomic
DNA from the two strains with expected bands
indicated by arrows.
(B) Colonies of wild-type (mc2155), mutant
(DMSMEG4722), and complemented
(DMSMEG4722-C) strains on TSB-agar () or
TSB-agar + 0.05% Tween-80 (+). Colony growth
shown in upper row was obtained by inoculating
5 ml of a broth culture on the agar plate, while the
lower row shows pictures of a single isolated
colony of each strain. Scale bar = 1 mm.
(C) Growth curve of wild-type (mc2155), mutant
(DMSMEG4722), and complemented
(DMSMEG4722-C) strains in TSB.
rate than the parental mc2155 strain
(Figure 2C; the OD600 values at 24h corre-
spond to 2 3 108 and 107 colony forming
units/ml for mc2155 and DMSMEG4722,
respectively). This was not surprising,
as a similar growth defect was observed
when the homologous gene was deleted
in C. glutamicum, and a genome-wide
transposon screen predicted that the
loss of the homologous gene in M. tuber-
culosis would result in a slow-growth
phenotype (Lea-Smith et al., 2007; Sas-
setti et al., 2003). Additionally, when
grown in Luria-Bertani broth (LB), the
mutant showed an increased sensitivity
to the lipophilic antibiotic rifampicin (min-
imum inhibitory concentrations [MIC] =
0.125 mg/ml) as compared with the paren-
tal strain mc2155 (MIC = 16 mg/ml), but not
to hydrophilic antibiotics, such as isonia-
zid and ethambutol. Wild-type character-
istics were restored on complementation
of the DMSMEG4722 mutant with plasmid-borne MSMEG4722,
indicating that the observed phenotypes in the mutant strain
were solely due to the loss of MSMEG4722 (Figures 2B and 2C).
The DMSMEG4722 Mutant Failed to Synthesize
Mature Mycolic Acids
The predicted role of MSMEG4722 in mycolic acid motif forma-
tion and the observed changes in the colony morphology of the
DMSMEG4722 mutant prompted us to examine mycolic acids in
932 Chemistry & Biology 15, 930–939, September 22, 2008 ª2008 Elsevier Ltd All rights reserved
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alyzing the conversion of the post-Pks13, a-alkyl, b-oxo fatty
acyl intermediate, then the DMSMEG4722 mutant would be
expected to accumulate this unreduced intermediate of mycolic
acid biosynthesis (Figure 1A). A standard procedure for release
of mycolic acids from mycobacteria involves base hydrolysis of
cells with tetrabutyl ammonium hydroxide (TBAH). This is fol-
lowed by phase-transfer catalyzed derivatization with methyl
iodide that results in the formation of mycolic acid methyl esters
(MAMEs) (Dobson et al., 1985), which are analyzed by thin-layer
chromatography (TLC). Following base treatment and derivatiza-
tion, [14C]-labeled extracts obtained from strains were analyzed
by TLC. While a, a0 and epoxy MAMEs were present in the paren-
tal mc2155 strain, all three species were missing in the extract
from the DMSMEG4722 strain (Figure 3A). Instead, the mutant
strain showed the accumulation of a product(s) with a higher re-
tardation factor (Rf) migrating above the fatty acid methyl esters
(FAMEs). When extracts from the mutant strain were analyzed by
2D-Ag+-argentation TLC, the rapidly migrating species resolved
into multiple subspecies in the second, Ag+-containing dimen-
sion, indicating the presence of multiple species differing in
degrees of unsaturation (Figure 3B). An identical result was
obtained for extracts from delipidated cells that only contain
cell wall-bound mycolates (Figure 3A), indicating that the ob-
served changes in mycolate profiles applied to both total and
specifically cell wall-bound mycolates.
Mycolic acid biosynthesis was restored in the mutant strain
following complementation with not only MSMEG4722, but
also Rv2509, indicating that Rv2509 was a functional homolog
of MSMEG4722 in M. tuberculosis (strains DMSMEG4722-C
and DMSMEG4722-CRv, respectively; Figure 3A).
The DMSMEG4722 Mutant Accumulates Precursors
of Mycolic Acids in the Cell Wall
The complete absence of a, a0 and epoxy MAMEs and the
appearance of rapidly migrating species in extracts of the
DMSMEG4722 mutant suggest that these rapidly migrating spe-
cies may either be precursors of mycolates or decomposition
products of precursors generated as a result of the extraction
procedure. The latter seemed more likely, as base treatment of
an unreduced a-alkyl, b-oxo fatty acid precursor, containing
two oxo groups in close proximity, has been shown to result in
the generation of a palmitone-like decomposition product in cor-
ynebacteria (Walker et al., 1973). Such decomposition products
would be expected to migrate similarly to the rapidly migrating
species that were observed in the extracts of the mutant strain.
To confirm whether unreduced precursors of a, a0 and epoxy
mycolic acids were present in the mutant strain, cells were pre-
treated with sodium borohydride (NaBH4). This pretreatment has
little effect on normal mycolates, but results in the reduction of
the b-oxo group in putative a-alkyl, b-oxo fatty acyl intermedi-
ates, resulting in the formation of a-alkyl, b-hydroxy products,
viz. mature mycolic acids. Thus, if the a-alkyl, b-oxo fatty acid
precursors of a, a0 and epoxy mycolic acids did exist in the
mutant strain, pretreatment with NaBH4 would be expected to
convert these precursors into a, a0 and epoxy mycolic acids,
and TLC analysis of TBAH-treated, methylated extracts from
NaBH4-pretreated DMSMEG4722 cells would show the pres-
ence of a, a0 and epoxy MAMEs due to the prior reduction ofChemistry & Biology 15, 930–9the b-oxo group. When extracts of NaBH4-pretreated cells
were analyzed by TLC, species migrating with the sameRf values
as a, a0 and epoxy MAMEs were observed (Figure 3C). However,
additional MAMEs were also present in the extracts. Two closely
migrating species had a very low Rf value, and were detected in
total mycolates strains from all strains (MAME-I; Figure 3C), while
another with anRf value slightly greater than a-MAMEs was seen
only in extracts from the mutant strain (MAME-II; Figure 3C).
MAME-I corresponded in chromatographic migration to two
hydroxylated artifacts, characterized previously in acid
Figure 3. TLC Analysis of Mycolic Acid Methyl Esters
(A) TLC analysis of MAMEs extracted from mc2155, DMSMEG4722,
DMSMEG4722-C, and DMSMEG4722-CRv strains. The rapidly migrating spe-
cies observed in DMSMEG4722 are indicated by a question mark. FAMEs,
fatty acid methyl esters.
(B) 2D Ag+-TLC of MAMEs extracted from mc2155, DMSMEG4722, and
DMSMEG4722-C. UFAMEs, unsaturated fatty acid methyl esters.
(C) TLC analysis of MAMEs extracted from cells pretreated with NaBH4.39, September 22, 2008 ª2008 Elsevier Ltd All rights reserved 933
Chemistry & Biology
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Total Carbon No. of Mycolic Acid
62 64 74 75 76 77 78 79 80
Untreated
WT
a0 952a 980a
a 1118 1132 1146 1160a 1174 1188a
Epoxy 1148 1162 1176a 1190 1204a 1218
NaBH4 treated
WT
a0 952a 980a
a 1118 1132 1146 1160a 1174 1188a
Epoxy 1162 1176a 1190 1204a
Hydroxyl 1178 1206 1220
DMSMEG4722
a0 952a 980a
a 1118 1146 1160a 1188a
a-epib 1160a 1188a
Epoxy 1176a 1190
Hydroxyl 1177
DMSMEG4722-C
a0 952a 980a
a 1118 1132 1146 1160a 1174 1188a
Epoxy 1162 1176a 1190 1204a
Hydroxyl 1178 1206 1220
The masses indicated are those of Na adducts.
a Masses of predominant species.
ba-epi is the isomer of a-mycolates.methanolysates of mycobacteria having epoxy mycolates (Min-
nikin et al., 1982). Similar hydroxylated artifacts would be ex-
pected by NaBH4 reduction of the epoxy group in epoxy myco-
lates. Mass spectroscopic (MS) analysis confirmed these
findings with molecular sizes detected in all strains correspond-
ing to those of a, a0, epoxy MAMEs, and to the reduced, hydrox-
ylated products of epoxy MAMEs (Table 1). Similar results were
obtained when the analyses were performed on delipidated
cells, indicating that the a-alkyl, b-oxo fatty acyl precursors of
mycolates from M. smegmatis were esterified to the AG in the
cell wall (Figure 3C). However, in this case, only a single
MAME-I hydroxylated component was produced on NaBH4-re-
duction of the delipidated cells (Figure 3C).
The NaBH4-reduction of the b-oxo group, in a mycolate
precursor, would result in two diastereoisomers of MAMEs, which
would migrate differently on TLC (Minnikin and Polgar, 1966).
MAME-II, therefore, was likely to be a mycolate b-epimer and,
on matrix-assisted laser desorption ionization-time of flight/MS
(MALDI-TOF/MS), the molecular size was found to be identical
to that of a-MAMES. Indeed, purified MAME-II comigrated with
a known standard for a-MAME b-epimer (data not shown). These
results showed that theDMSMEG4722mutant, due to loss of my-
colyl reductase function, failed to make mature mycolic acids,
and instead synthesized the a-alkyl, b-oxo fatty acyl precursors
of a, a0 and epoxy mycolates that were transported and subse-
quently esterified to the reducing termini of the AG complex.934 Chemistry & Biology 15, 930–939, September 22, 2008 ª2008 ELipid Analysis Revealed Accumulation of a Nonpolar
Lipid in the DMSMEG4722 Mutant
Polar and nonpolar lipids labeled with [14C]-acetate were ex-
tracted from mc2155, DMSMEG4722, and DMSMEG4722-C
strains and analyzed by 2D-TLC (Dobson et al., 1985). Interest-
ingly, the lipids corresponding to TMM and TDM in mc2155
were replaced by two lipids with slightly altered mobilities in
the mutant strain (Figure 4A). Both lipids had a slightly higher
Rf value (Rf = 0.147 and Rf = 0.39) than parental TMM and
TDM (Rf = 0.117 andRf = 0.36) in direction 1. This altered mobility
was likely due to esterification of the a-alkyl, b-oxo mycolic acid
precursors (instead of mature mycolic acids) to trehalose in the
mutant strain, as was observed in the C. glutamicum mutant
(Lea-Smith et al., 2007). Furthermore, the mutant strain showed
accumulation of a nonpolar species accompanied by a total loss
of free mycolic acids (Figures 4B and 4C). This lipid species,
referred to as Lipid-Y, did not stain with Dittmer-Lester reagent
or with a-napthol-sulfuric acid, indicating the absence of phos-
phate groups and carbohydrates (data not shown). Following
purification by preparative TLC, Lipid-Y was characterized by
MALDI-TOF/MS and nuclear magnetic resonance (NMR) (Fig-
ure 5). Three species of m/z 907.6, 935.6, and 963.6 were ob-
served in the mass spectra (Figure 5A), indicating a difference
of m/z 28 between each species. Further, 1H-NMR and 13C-
NMR revealed a signal characteristic of CH2 groups (1.3
and 30 ppm, respectively), and indicated the presence of alkyllsevier Ltd All rights reserved
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1H-NMR and 13C-NMR
provided evidence of the presence of cis and/or trans double
bonds (Figures 5B–5D; 1, 2, 3), with the latter possessing an
adjacent methyl branch (Figures 5B–5D; 5) and a keto group (Fig-
ures 5C and 5D; 14), suggesting that Lipid-Y was a mixture of cis-
and trans-unsaturated long-chain ketones (Figure 5D). Based on
the masses obtained by MALDI-TOF/MS, these unsaturated,
branched ketones were of chain lengths C62, C64, or C66. Since
the accumulation of Lipid-Y was accompanied by a loss of my-
colates (and no detectable free a-alkyl, b-oxo mycolate precur-
sors), it seemed likely that the ketones that comprised Lipid-Y
were derived from free b-oxo precursors. Free a-alkyl, b-oxo
mycolate precursors could undergo decarboxylation to form
ketones. If this was the case, then the oxo group would be situ-
ated between alkyl chains that originate from a meroacid on one
side and the a branch on the other. Through the use of electron
impact-MS (EI-MS), we were able to confirm the presence of a
fragment of m/z 351, corresponding to the a chain (C22) plus a
carbonyl group. In addition, the detection of fragments of m/z
546, 574, and 602, corresponding to C39, C41, and C43 monoun-
saturated alkyl chains, respectively, further substantiated our
findings.
DISCUSSION
With the exception of KasB, all enzymes involved in the biosyn-
thesis of mycolic acids in mycobacterial species are encoded by
Figure 4. 2D-TLC Analysis of Apolar Lipids
Extracted from mc2155, DMSMEG4722,
and DMSMEG4722-CStrains
(A) Direction 1, chloroform:methanol:water,
100:14:0.8 (v/v); direction 2, chloroform:acetone:
methanol:water, 50:60:2.5:3 (v/v). GMM, glucose
monomycolate; TDM, trehalose dimycolate;
TMM, trehalose monomycolate.
(B) Direction 1, petroleum ether:acetone, 98:2 (v/v,
thrice); direction 2, toluene:acetone, 98:2 (v/v).
Lipid-Y is indicated by an arrow and question
mark.
(C) Direction 1, chloroform:methanol, 96:4 (v/v);
direction 2, toluene:acetone, 80:20 (v/v). MA,
mycolic acids.
essential genes (Bhatt et al., 2005; Brown
et al., 2007; Parish et al., 2007; Portevin
et al., 2004; Sacco et al., 2007). However,
we were able to generate a viable null
mutant ofMSMEG4722, the gene that en-
codes the reductase involved in mycolic
acid motif synthesis in M. smegmatis.
This was not entirely surprising, because
global transposon mutagenesis screens
predicted insertions in Rv2509, the
M. tuberculosis homolog of MSMEG4722,
to result in a slow-growth phenotype.
Indeed, the DMSMEG4722 mutant did
exhibit a slow growth rate similar to that
observed in C. glutamicum (Lea-Smith
et al., 2007).
Alkaline hydrolysis of the parental strainM. smegmatismc2155
released a, a0 and epoxy mycolates, as expected, but hydro-
lyzates of the DMSMEG4722 mutant showed no evidence of
mycolates (Figure 3A). Instead, hydrolyzates of the mutant
DMSMEG4722 showed the presence of rapidly migrating com-
ponents (Figures 3A and 3B, labeled ‘‘?’’). If the DMSMEG4722
mutant was accumulating a-alkyl, b-oxo mycolate precursors,
alkaline hydrolysis would produce unstable b-oxo acids, which
would lose carbon dioxide to yield long-chain ketones. Through
an alternative approach, we confirmed the presence of the
a-alkyl, b-oxo fatty acyl precursors by converting them to a-alkyl,
b-hydroxy fatty acids (mycolates) by prior reduction of bound
mycolates with NaBH4. This resulted in the appearance of a,
a0 and epoxy-MAMEs in extracts of both whole and delipidated
cells from the mutant strain (Figure 3C).
As expected (Minnikin and Polgar, 1966), reduction of the
b-oxo mycolate precursors gave a mixture of separable diaste-
reoisomers, and the presence of the b-epimer of a-MAME was
clearly seen (MAME-II; Figure 3C). It would be expected that
the b-epimers of a0 and epoxy mycolates would also be pro-
duced, but such minor compounds would not be readily seen
on 1D-TLC (Figure 3C). The epoxy function is also susceptible
to NaBH4 reduction and isomeric hydroxylated derivatives
were identified (MAME-I; Figure 3C), corresponding to two arti-
facts previously characterized in acid methanolysates (Minnikin
et al., 1982). However, reduction of the delipidated cells gave
only the most polar hydroxylated derivative (Figure 3C). This
Chemistry & Biology 15, 930–939, September 22, 2008 ª2008 Elsevier Ltd All rights reserved 935
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(A–D) (A) MALDI-TOF/MS, (B) 1H-NMR, and (C) 13C-NMR of purified Lipid-Y. Characteristic shifts are labeled as numbers, and the structures they represent are
indicated in (D).strongly suggests that access of NaBH4 to cell wall-bound epoxy
mycolates was restricted. It has recently been shown that keto
mycolates from Mycobacterium bovis BCG adopt a folded ‘‘W’’
conformation (Villeneuve et al., 2007) with the keto group in a
similar hydrophilic environment as the hydroxy acid unit. It is
reasonable to suggest that bound epoxy mycolic acids might
also prefer such a folded ‘‘W’’ conformation that could direct
the access of NaBH4 in a regiospecific manner, resulting in the
formation of only a single hydroxylated derivative. It is notable
that the covalently bound b-oxo precursors in theDMSMEG4722
mutant also produce only the more polar derivative. This would
suggest that b-oxo precursors also fold in the same way as intact
mycolates, indicating that a b-hydroxy group is not an absolutely
essential prerequisite for folding in a ‘‘W’’ conformation. Indeed,
the fact that DMSMEG4722 mutant cells are viable, with b-oxo
mycolate analogs in their envelopes, strongly suggests that
an exchange of a native b-hydroxy group for an unnatural
b-oxo unit is permitted. However, as discussed later, the
DMSMEG4722 mutant cells were more permeable to lipophilic
antibiotics, and colony morphology was affected. Further stud-
ies will be needed to clarify these intriguing observations.
Additionally, replacement of TMM and TDM with derivatives
with slightly altered TLC mobility in DMSMEG4722 (Figure 4A)
suggest that the a-alkyl, b-oxo mycolate precursors were also
esterified to trehalose. Indeed, we obtained similar results for936 Chemistry & Biology 15, 930–939, September 22, 2008 ª2008 EMAME analysis from extracts of whole cells (which contain
wall-bound and trehalose-bound mycolates) as well as delipi-
dated cells (which contain only wall-bound mycolates), demon-
strating that mycolic acids in both the mAGP complex and in
TMM/TDM were replaced by the a-alkyl, b-oxo fatty acid
precursors.
While the loss of the reductase was expected to generate pre-
cursors of mycolic acids, it was surprising that the a-alkyl, b-oxo
fatty acids were associated with the cell wall. These data suggest
that mycobacterial components involved in the processing,
transport, and subsequent transfer of mycolic acids to the cell
wall (including the hypothetical mycolyl transferases I and II and
the proteins of the antigen 85 complex [Takayama et al., 2005])
were probably able to do the same with the a-alkyl, b-oxo fatty
acid intermediates. In contrast, Lea-Smith et al. (2007) reported
reduced levels of AG-mycolylation in the C. glutamicum reduc-
tase mutant (DNCgl2385). Corynomycolate derivatives released
from mutant cell wall were distinct from wild-type corynomyco-
lates, and showed an 80% reduction in abundance. However,
the extraction method used in this previous study involved
acid-methanolyis. In light of our findings, it is likely that, rather
than a reduction in mycolylation, the DNCgl2385 mutant con-
tained equally abundant a-alkyl, b-oxo corynomycolate precur-
sors esterified to the AG, which were not detected by GC and
MS because of decomposition resulting from acid-methanolysis.lsevier Ltd All rights reserved
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stead of mycolic acids in the cell wall, had a significant impact
on the characteristics of the cell wall of M. smegmatis, rendering
the mutant strain more susceptible to lipophilic antibiotics due to
an increased permeability. The presence on a b-oxo rather than
a b-hydroxyl group also affected the colony morphology of the
mutant strain, presumably due to changes in the hydrophobicity
of the outer surface of the bacterial cells.
A key distinction between the reductase mutants of C. gluta-
micum and M. smegmatis was the accumulation of an unusual
lipid, Lipid-Y, in the latter. MS and NMR analyses of purified
Lipid-Y revealed it to be a mixture of unsaturated, branched
ketones. Similar ketones were detected in strains of M. tubercu-
losis (tuberculenone) and Corynebacterium diptheriae (Asseli-
neau, 1954; Pudles and Lederer, 1954). The total number of
carbons (C60 ± C3) in the monounsaturated M. tuberculosis
ketone, tuberculenone is similar to those of Lipid-Y (C62–C66) in
the MSMEG4722 mutant. However, tuberculenone was charac-
terized before the advent of mass spectrometry (Asselineau,
1954), so precise comparisons are not meaningful. It has been
suggested that ketones like tuberculenone are derived from de-
carboxylation of the a-alkyl, b-oxo fatty acid intermediates of
mycolic acids (Asselineau, 1966). In addition to cell wall-bound
and glycolipid-associated mycolates, mycobacteria also contain
free mycolic acids, and would be expected to contain some tran-
sient, unreduced mycolic acid intermediates at any given time. It
is likely that tuberculenone is derived from these intermediates.
In the DMSMEG4722 mutant, however, no free mycolic acids
were detected (Figure 4C). Instead, an accumulation of a-alkyl,
b-oxo fatty acid intermediates would be expected to occur.
Free acids of such intermediates would then undergo decarbox-
ylation to form the ketones that comprise Lipid-Y. Through the
use of EI-MS, we were able to confirm that this was indeed the
case.
Environmental mycobacteria are known to alter cell wall myco-
late composition in response to growth substrates, resulting in
a more hydrophobic wall when grown in the presence of hydro-
phobic substrates (Wick et al., 2002). It is not clear whether
mycolate reduction is regulated by environmental factors, but
our studies here have shown that loss of the b-hydroxy mycolate
motif reduction alters cell wall hydrophobicity. Whether this has
an effect in vivo (in the case of M. tuberculosis) remains to be
studied.
In conclusion, our results clearly demonstrate that
MSMEG4722 is the reductase involved in generation of the my-
colic acid motif in M. smegmatis. The loss of this function is not
lethal, allowing cell wall incorporation of b-oxo mycolate ana-
logs, but affecting the growth characteristics of the bacterium.
SIGNIFICANCE
Mycolic acid biosynthesis is essential for mycobacterial sur-
vival and many antituberculosis drugs, such as isoniazid,
ethionamide, and thiolactomycin, target enzymes of this ex-
clusive pathway (Banerjee et al., 1994; Kremer et al., 2000).
Interestingly, MSMEG4722, which catalyzes the final step
in mycolic acid biosynthesis in Mycobacterium smegmatis,
is nonessential, and a-alkyl, b-oxo mycolate precursors
are attached to arabinogalactan and trehalose. However,Chemistry & Biology 15, 930–we have demonstrated that loss of function does cause ma-
jor changes in the cell wall ofM. smegmatis, making it more
susceptible to lipophilic antibiotics, such as rifampicin. By
extension, loss of Rv2509, the Mycobacterium tuberculosis
homolog, would be expected to have a bearing not only on
susceptibility to antibiotics, but also on virulence, as strains
of M. tuberculosis with altered mycolic acids are highly at-
tenuated (Bhatt et al., 2007; Dubnau et al., 2000; Glickman
et al., 2000), highlighting the potential of Rv2509 as a ‘‘sec-
ondary’’ drug target. Our studies also shed some light on
the post-fatty acid synthase-II/Pks13 processing, transport,
and transfer of mycolic acids to their location in the cell
envelope. The replacement of mycolic acids in the cell wall
by the a-alkyl, b-oxo fatty acid precursors suggested that
post-Pks13 reduction of the b-oxo group was not necessary
for the subsequent processing pathways.
EXPERIMENTAL PROCEDURES
Bacterial Strains, Phages, Plasmids, and Culture Conditions
All plasmids, phages, and bacterial strains used in this study are shown in
Table 2. Strains of E. coli were cultured in LB (Difco). M. smegmatis strains
were grown in either LB broth or tryptic soy broth (TSB; Difco), each containing
0.05% Tween-80. TSB-agar was prepared by adding 1.5% agar to TSB prior
to autoclaving. For M. smegmatis, hygromycin (100 mg ml1) or kanamycin
(20 mg ml1) was used for selection, while hygromycin (150 mg ml1) or kana-
mycin (40 mg ml1) was used for selecting recombinant E. coli strains. Deter-
mination of MIC of antibiotics was done in LB with the Alamar blue assay
(Franzblau et al., 1998).
Bioinformatics
Sequence alignments were determined with BLAST or EBI ClustalW (Chenna
et al., 2003), and rendered with the EScript 2.2 Web server. Structural predic-
tions were performed with the @TOME server (Douguet and Labesse, 2001),
and modeling performed with the FUGUE Web server (http://tardis.nibio.go.
jp/fugue/align.php). PyMOL (DeLano Scientific) was used to create POV
scenes followed by rendering by POV-Ray.
Construction of aMSMEG4722 Null Mutant
Approximately 1 kb sequences of the upstream and downstream regions of
MSMEG4722 were PCR-amplified from M. smegmatis mc2155 genomic
DNA with the primer pairs MS4722LL (50-TTTTTTTTCCATAAATTGGTGGCC
AGCAGGT AGTAGACG-30) and MS4722LR (50-TTTTTTTTCCATTTCTTGGAG
TTCGGTGGCCAACG CTTC-30), and MS4722RL (50-TTTTTTTTCCATAGATTG
GTGGATCGACACCGAGTAC AC-30 ) and MS4722RR (50-TTTTTTTTCCATCTT
TTGGAAACTGATCCGCTCCAAGGG-30), respectively (all primers had Van91I
recognition sites incorporated at the 50 end). The PCR fragments were
digested with Van91I and directly cloned into Van91I-digested p0004S (gift
from T. Hsu and W.R. Jacobs Jr., Albert Einstein College of Medicine, NY).
Recombinant plasmids obtained after transforming E. coli TOP-10 cells were
digested with Van91I for confirmation and sequenced. One plasmid,
pDMSMEG4722, was linearized by PacI digestion and packaged into the tem-
perature-sensitive mycobacteriophage phAE159, as previously described
(Bardarov et al., 2002), to yield phasmid DNA of the knockout phage
phDMSMEG4722. Generation of high-titer phage particles and specialized
transduction were performed as described previously (Bardarov et al.,
2002). Allelic exchange in hygromycin-resistant transductants was confirmed
by Southern blot.
Construction of Complemented Strains
MSMEG4722 was PCR amplified from M. smegmatis mc2155 genomic DNA
with the primers MS4722-U (50-GCAGGATCCAATGAGCCGCATGCCAGTA
CCCG-30) and MS4722-D (50-GCAGAATTCCTAACCGCCGCCGAGCTTCTT
G-30) and cloned into the E. coli-Mycobacterium shuttle plasmid pMV261
with the primer-incorporated BamHI and EcoRI sites, to yield the recombinant939, September 22, 2008 ª2008 Elsevier Ltd All rights reserved 937
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Mycobacterial Mycolic Acid ReductaseTable 2. Plasmids, Bacterial Strains, and Phages Used in This Study
Description Reference/Source
Plasmids
pMV261 E. coli-Mycobacterium shuttle plasmid vector with
hsp60 promoter and KanR cassette (aph)
Stover et al. (1991)
pMV261-MSMEG4722 MSMEG4722 cloned in pMV261 This work
pMV261-Rv2509 Rv2509 cloned in pMV261 This work
p0004s Vector for cloning allelic-exchange substrates to be
used for specialized transduction; contains l phage
cos site and HygR cassette (hyg)
Gift from T. Hsu and W.R. Jacobs, Jr.,
Albert Einstein College of Medicine,
New York
pDMSMEG4722 Derivative of p0004s designed for allelic exchange of
M. smegmatis MSMEG4722
This work
Bacterial strains
mc2155 Electroporation-proficient ept mutant of M. smegmatis
strain mc26
Snapper et al. (1990)
DMSMEG4722 Deletion mutant of mc2155 in which MSMEG4722 is
replaced by hyg
This work
DMSMEG4722-C Complemented strain of DMSMEG4722 containing
pMV261-MSMEG4722
This work
DMSMEG4722-CRv Complemented strain of DMSMEG4722 containing
pMV261-Rv2509
This work
Phages
phAE159 Conditionally replicating shuttle phasmid derived from
the lytic mycobacteriophage TM4
Bardarov et al. (2002)
phDMSMEG4722 Derivative of phAE159 obtained by cloning
pDMSMEG4722 into its unique PacI site
This workplasmid pMV261-MSMEG4722. In a similar fashion, the plasmid pMV261-
Rv2509 was constructed with Rv2509, which was PCR amplified from
M. tuberculosis H37Rv genomic DNA with the primers Rv2509-U (50-GCAGGA
TCCAATGCCGATACCCGCGCCC-30) and Rv2509-D (50-GCAGAATTCCTA
GCTGCCCCCAAGCCTC-30). The complemented strains DMSMEG4722-C
and DMSMEG4722-CRv were obtained by selecting kanamycin-resistant
transformants following electroporation of the mutant strain DMSMEG4722
with pMV261-MSMEG4722 or pMV261-Rv2509 respectively. Electroporation
was performed as previously described (Snapper et al., 1990).
Lipid and Mycolic Acid Extraction and Analysis
Polar and apolar lipids were extracted fromM. smegmatis strains and analyzed
as described previously (Dobson et al., 1985). For extraction of MAMEs, both
the delipidated cells and the whole-cell pellets were subjected to alkaline hy-
drolysis with 5% aqueous TBAH at 100C overnight, followed by the addition
of 4 ml CH2Cl2, 500 ml CH3I, 2 ml water, followed by mixing for 30 min. The
upper aqueous phase was discarded following centrifugation, and the lower
organic phase washed thrice with water and evaporated to dryness. The re-
sulting FAMEs and MAMEs were dissolved in diethyl ether, insoluble residues
were removed by centrifugation, and the ether solution evaporated to dryness
and redissolved in 200 ml of CH2Cl2. Equivalent volumes of the resulting solu-
tion of FAMEs and MAMEs was subjected to TLC with silica gel plates (5735
silica gel 60F254; Merck, Darmstadt, Germany), developed in petroleum
ether-acetone (95:5). Autoradiograms were produced by overnight exposure
of Kodak X-Omat AR film to the plates to reveal [14C]-labeled FAMEs and
MAMEs. Argentation-TLC was performed as described above after saturation
of TLC plates with 10% aqueous silver nitrate solution and prior activation at
100C for 1 hr. Lipid-Y was purified by preparative silica gel TLC with petro-
leum ether:ethyl acetate (98:2, v/v) and detection by spraying with ethanolic
Rhodamine 6G to visualize the lipid under a 366 nm UV lamp. The area contain-
ing Lipid-Y was removed and extracted from the silica gel with diethyl ether.
The extracted sample was then resolved on a second TLC plate in toluene:
acetone (95:5, v/v) and purified as described above. MALDI-TOF/MS of all
samples was performed with the Voyager DE-STR MALDI-TOF instrument
(PerSeptive Biosystems, Framingham, MA). NMR spectra for Lipid-Y were re-938 Chemistry & Biology 15, 930–939, September 22, 2008 ª2008 Ecorded in CDCl3 on a Bruker DRX500 operating at 500.13 MHz for
1H-NMR
and 125.77 MHz for 13C-NMR.
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